Comparison of 131I- and 90Y-labeled monoclonal antibody 17-1A for treatment of human colon cancer xenografts.

[1]  P. Roberson,et al.  Variations in 3-D dose distributions for 131indium-labeled monoclonal antibody , 1992 .

[2]  R K Ten Haken,et al.  Three-dimensional tumor dosimetry for radioimmunotherapy using serial autoradiography. , 1992, International journal of radiation oncology, biology, physics.

[3]  S. Order,et al.  Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  S. Kennel,et al.  Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts. , 1991, Cancer research.

[5]  T. Lawrence,et al.  Tumor therapy with radiolabeled monoclonal antibodies , 1991 .

[6]  M. Brechbiel,et al.  Comparison of five bifunctional chelate techniques for 90Y-labeled monoclonal antibody CO17-1A. , 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[7]  O. Gansow.  Newer approaches to the radiolabeling of monoclonal antibodies by use of metal chelates. , 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[8]  R. Nath,et al.  Iododeoxyuridine radiosensitization by low- and high-energy photons for brachytherapy dose rates. , 1990, Radiation research.

[9]  Z. Steplewski,et al.  Radioimmunotherapy of human colorectal carcinoma xenografts using 90Y-labeled monoclonal antibody CO17-1A prepared by two bifunctional chelate techniques. , 1990, Cancer research.

[10]  M. Brechbiel,et al.  Selection of a dtpa chelate conjugate for monoclonal antibody targeting to a human colonic tumor in nude mice , 1990, International journal of cancer.

[11]  B. Wessels,et al.  Targeting of human glioma xenografts in vivo utilizing radiolabeled antibodies. , 1990, International journal of radiation oncology, biology, physics.

[12]  J. Schlom,et al.  Advantage of dose fractionation in monoclonal antibody-targeted radioimmunotherapy. , 1990, Journal of the National Cancer Institute.

[13]  A. Glatfelter,et al.  A comparison of 131I-labeled monoclonal antibody 17-1A treatment to external beam irradiation on the growth of LS174T human colon carcinoma xenografts. , 1990, International journal of radiation oncology, biology, physics.

[14]  D. Goldenberg,et al.  Biodistribution and radiation dose estimates for yttrium- and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xenografts. , 1990, Cancer research.

[15]  A. Glatfelter,et al.  Comparative binding and preclinical localization and therapy studies with radiolabeled human chimeric and murine 17-1A monoclonal antibodies. , 1990, Cancer Research.

[16]  W. Slizofski.  Bone SPECF Evaluation of Patients with Persistent Back Pain Following Lumbar Spinal Fusion , 1989 .

[17]  W. V. Prestwich,et al.  Beta dose point kernels for radionuclides of potential use in radioimmunotherapy. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  S. Mirzadeh,et al.  Comparative biodistributions of yttrium- and indium-labeled monoclonal antibody B72.3 in athymic mice bearing human colon carcinoma xenografts. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  D. Goldenberg,et al.  Reduction of radioantibody-induced myelotoxicity in hamsters by recombinant interleukin-1. , 1988, Cancer research.

[20]  J. Juni,et al.  Localization and imaging of radiolabeled monoclonal antibodies against colorectal carcinoma in tumor-bearing nude mice. , 1988, Cancer research.

[21]  W. Hawkins,et al.  Dosimetry and treatment planning for 90Y-labeled antiferritin in hepatoma. , 1988, International journal of radiation oncology, biology, physics.

[22]  S. Jewell,et al.  Tumor-associated antigen expression of primary and metastatic colon carcinomas detected by monoclonal antibody 17-1A. , 1987, American journal of clinical pathology.

[23]  J. Douillard,et al.  Immunohistochemical antigenic expression and in vivo tumor uptake of monoclonal antibodies with specificity for tumors of the gastrointestinal tract. , 1986, Cancer research.

[24]  D. E. Simpson,et al.  Synthesis of 1-(p-isothiocyanatobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumor-imaging studies , 1986 .

[25]  P. Doherty,et al.  DTPA-coupled antibodies labeled with yttrium-90. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  F. Buchegger,et al.  Radiolabeling of monoclonal antibody against carcinoembryonic antigen with 88Y and biodistribution studies. , 1985, International journal of nuclear medicine and biology.

[27]  B. Wessels,et al.  Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies. , 1984, Medical physics.

[28]  J. Douillard,et al.  Immunoscintigraphy of colon carcinoma. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  M. Herlyn,et al.  Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[30]  P. Fraker,et al.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. , 1978, Biochemical and biophysical research communications.